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Substantial tissue motion (>1cm) arises in the thoracic/abdominal cavity due to res-
piration. There are many clinical applications in which localizing tissue with high ac-
curacy (<1mm) is important. Potential applications include radiation therapy, radio
frequency ablation, lung/liver biopsies, and brachytherapy seed placement. Recent
efforts have made highly accurate sub-mm 3D localization of discrete points available
via electromagnetic (EM) position monitoring. Technology from Calypso Medical R©
allows for simultaneous tracking of up to three implanted wireless transponders. Ad-
ditionally, Medtronic Navigation uses wired electromagnetic tracking to guide surgical
tools for image guided surgery (IGS).
Utilizing real-time EM position monitoring, a prototype system was developed to
guide a therapeutic linear accelerator to follow a moving target (tumor) within the
lung/abdomen. In a clinical setting, electromagnetic transponders would be bron-
choscopically implanted into the lung of the patient in or near the tumor. These
transponders would affix to the lung tissue in a stable manner and allow real-time
ii
position knowledge throughout a course of radiation therapy. During each dose of
radiation, the beam is either halted when the target is outside of a given threshold,
or in a later study the beam follows the target in real-time based on the EM position
monitoring. We present quantitative analysis of the accuracy and efficiency of the
radiation therapy tumor tracking system.
EM tracking shows promise for IGS applications. Tracking the position of the instru-
ment tip allows for minimally invasive intervention and alleviates the trauma asso-
ciated with conventional surgery. Current clinical IGS implementations are limited
to static targets: e.g. craniospinal, neurological, and orthopedic intervention. We
present work on the development of a respiratory correlated image guided surgery
(RCIGS) system. In the RCIGS system, target positions are modeled via respira-
tory correlated imaging (4DCT) coupled with a breathing surrogate representative of
the patient’s respiratory phase/amplitude. Once the target position is known with
respect to the surrogate, intervention can be performed when the target is in the
correct location. The RCIGS system consists of imaging techniques and custom de-
veloped software to give visual and auditory feedback to the surgeon indicating both
the proper location and time for intervention. Presented here are the details of the
IGS lung system along with quantitative results of the system accuracy in motion
phantom, ex-vivo porcine lung, and human cadaver environments.
iii
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The accuracy of intervention on targets within the body has increased in conjunction
with advances in technology. In areas ranging from surgery to radiation therapy,
treatments and diagnostic procedures are becoming more precise and less invasive.
For targets within the lung and abdomen, respiration causes substantial motion and
tissue deformation. Targets near the diaphragm can move at amplitudes up to several
centimeters. With recent advances in interventional techniques, the accuracy of many
systems are currently limited by respiratory motion. Failure to account for this motion
can lead to inaccuracies, complications and decrease the effectiveness of procedures
within the lung and abdomen.
For biopsies of targets within the lung, the diagnostic yield decreases as the spatial
error associated with the biopsy increases. It is more complicated to obtain accurate
samples of mobile targets due to the fact that the physician is now intervening in both
space and time. Conventionally these procedures have been guided using real-time
imaging, such as fluoroscopy or ultrasound. In clinical use, both of these modalities
are limited to two dimensions. Fluoroscopic imaging delivers ionizing radiation to
both the surgeon and patient, and ultrasound suffers from low soft tissue contrast.
Many pulmonologists will only attempt biopsies on tumors of larger size (>1cm) due
to accuracy limitations. A more accurate means of intervening on mobile tumors
within the lung would allow physicians to biopsy smaller lesions; providing early
detection and improvement in patient outcomes.
Radio frequency ablation (RFA) also could benefit from respiratory correlated guid-
ance. In this technique, lesions are heated using a radio frequency probe. Currently
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RFA is commonly used for liver lesions, however clinically stereotactic radiosurgery
is preferred over RFA for lesions within the lung. Liver applications are currently
limited to regions far from the diaphragm and large blood vessels due to respiratory
motion and heat dissipation concerns respectively. Failure to account for respiratory
motion could lead to the probe being positioned incorrectly, resulting in ablation of
healthy tissue. A respiratory correlated intervention system for RFA has the potential
to increase accuracy and allow for minimally invasive procedures in the lung and liver
on targets proximal to the diaphragm.
In radiation oncology, linear accelerators are capable of delivering radiation to the pa-
tient with high accuracy (1 mm). Inaccuracies can result from daily routine patient
alignment, or respiratory motion within a treatment. Although most modern linear
accelerators are equipped with on-board imaging (OBI) systems, the computational
power needed to segment and determine a tumor location in real-time is not avail-
able. Additionally, many linear accelerators offer cone beam CT imaging, however
acquisition takes approximately 60 seconds and as a result motion blur artifacts are
substantial. In order to account for inaccuracies associated with the target position
and ensure the target receives the prescribed radiation dose, margins, or buffer areas
surrounding a target, are added and irradiated during the treatment. Current clinical
margins at Washington University Medical School for standard lung tumors are 1cm
additions on each side. Increasing the accuracy at which the target location is known
could result in decreased treatment margins and spare healthy tissue from irradiation.
Healthy tissue dose is the limiting factor in escalating the dose to tumors. It has been
shown for non-small cell lung cancer (NSCLC) that escalating the dose to the tumor
volume (>70 Gy) can provide better local control than lower doses (<70 Gy) [10, 77].
Increased accuracy in the presence of motion shows promise for escalating dose to the
tumor site while sparing surrounding healthy tissue.
A system from Calypso Medical provides small implantable wireless transponders
which are sequentially queried to report the position of up to three points within the
patient’s body. An array is placed above the patient, and the transponder positions
are monitored with respect to the array via electromagnetics. The specifics regarding
how the system works are described in Appendix B.9. Balter et al have reported
submillimeter accuracy when tracking the transponders moving at 3 cm/s in a volume
that is 14x14 cm in width, and up to 27 cm away from the source array [2]. In a
2
study from Santanam et al the system was again found to be sub-mm accurate as
confirmed by onboard kilovoltage imaging [78]. The system is currently FDA cleared
for use in the prostate, and potential applications in the lung and abdomen (where
motion is substantial) are promising.
Additionally, Medtronic Navigation has developed a system of tracking surgical in-
strument tips in real-time. The StealthStation system is currently used for cran-
iospinal applications in which the patient’s head is stationary. The system displays
the tool tip overlaid on an a priori acquired CT or MRI image. Guidance is pro-
vided in real-time to ensure the physician is taking the intended path to the target.
The system currently is not used for targeting within the lung or abdomen due to
respiratory motion and soft tissue deformation concerns. Surgical navigation within
these areas would be useful for tumor biopsies, radio frequency ablation (RFA), or
brachytherapy seed placement.
Imaging systems provide high spatial accuracy, however the temporal accuracy of
target localization is not suitable for real-time lung target interventions. Due to their
high temporal accuracy, the aforementioned electromagnetic systems have potential
to increase treatment capabilities in both radiation therapy as well as image guided
surgery procedures. This dissertation covers work associated with creating new inter-
ventional systems for lung applications by integrating electromagnetic tracking. In
the following chapters, these specific aims are addressed in more detail:
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1.1 Specific Aim 1: Incorporate real-time electro-
magnetic position monitoring into a spatial gat-
ing solution for motion management in the de-
livery of radiation therapy.
1.2 Specific Aim 2: Incorporate real-time electro-
magnetic position monitoring into a Dynamic
Multileaf Collimator (DMLC) tracking system
for highly accurate continuous radiation deliv-
ery to mobile targets
1.3 Specific Aim 3: Determine the accuracy of an
internal fiducial marker with known position
at predicting adjacent target motion.
1.4 Specific Aim 4: Develop a robust system for
image guided surgery (IGS) applications in the
presence of respiratory motion.
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Chapter 2
Linear Accelerator EM Gating
2.1 Introduction
The goal of radiation therapy is to maximize the absorbed dose to the target volume
while minimizing the dose to surrounding healthy tissue. Intrafraction motion due
to respiration can cause the tumor to move considerably throughout treatment. The
displacements associated with respiration can be up to 3 cm within the thorax. [41] To
account for this motion, radiation oncologists must incorporate substantial margins
(typically 1 cm superior/inferior and 0.5 cm for both anterior/posterior and lateral)
in the design of each planning target volume (PTV). This leads to large volumes
of irradiated normal tissue that can limit the total dose that the patient can safely
receive. This has led researchers to explore beam gating techniques with the goal of
more accurate radiation delivery to tumors impacted by respiratory motion.
Respiratory correlation has been used extensively in CT and MR imaging in an effort
to reduce breathing related image artifacts.[74, 69] More recently, similar techniques
have been employed to localize the tumor and gate the linear accelerator.[91, 49, 35,
37, 8] Conventional gating setups use a variety of techniques to measure breathing
motion including: optically tracked external marker blocks, thermocouples, thermis-
tors, strain gauges, and pneumotachographs.[38] Current techniques rely on the use
of external markers or sensors to determine the internal position of the target. Al-
though a correlation exists between external markers and internal tumor position, for
some patients external marker trajectories do not serve as an adequate surrogate for
internal tumor position.[16]
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Respiration induces considerable deformation within the thoracic cavity. As the di-
aphragm contracts, internal anatomy compresses and distends. Often the external
anatomy exhibits good correlation with the motion of the internal structures such
as the diaphragm and/or lung tumors.[49, 16] The external anatomy moves due to
respiration, however studies have shown considerable differences between external
anatomy and internal motion. These differences can come in the form correlated mo-
tion with a phase lag between the external and internal motion, or less frequently the
motion might not exhibit correlation. Margeras and Yorke have reported up to a 0.5
second lag between Varian RPM marker block position and diaphragm position mea-
sured fluoroscopically.[51] Koch et al found that correlation was poor and unstable
unless the external surrogate measuring skin surface position was near the tumor.[36]
In a study from Berbeco et al, lung tumor motion was measured via continuous flu-
oroscopy concurrently with measurement of external abdominal surface positions.[7]
The amount of residual tumor motion, defined as the amount of tumor motion during
a respiratory gate based upon the movement of the external surrogate, showed large
fluctuations (>300%) for both intra- and inter-fraction motion. The residual motion
was found to be up to 8 mm in magnitude, which strongly suggests that external
position monitoring cannot accurately reflect the internal position of a tumor for all
cases. The periods in which external and internal motion exhibit poor correlation are
often transient; however these transient periods may have dosimetric implications.[68]
The lack of correlation between internal/external positions has led investigators to
examine alternative techniques for accurately tracking the position of targets inside
the thoracic cavity. Shirato et al developed a real-time target tracking system that
uses four integrated kilovoltage imaging systems.[89] The fluoroscopic imaging system
used in this technique provides accurate information on the location of discrete points
inside the abdomen. However, accurate tracking of the target comes at the expense of
an increased imaging dose. For a single fluoroscope, the estimated skin surface dose
rate can up be to 118 cGy/h.[93] In addition, for 3D target tracking, stereoscopic
fluoroscopes are necessary which means further accumulated dose due to imaging.
The SynchronyTMRespiratory Tracking System (RTS) treatment option of the Cy-
berKnife robotic radiotherapy system provides another image based system for track-
ing internal fiducial markers.[85] With this technique, gold fiducials are placed inside
the thoracic cavity near the tumor while the patient wears a vest with LEDs that
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indicate the position of the chest or abdomen. Before the treatment begins, a series
of orthogonal x-ray images are acquired that are used to correlate the position of the
external markers to the internal fiducials. A correspondence model is developed and
periodic images are obtained during the course of delivery to ensure the continued
validity of the correspondence model. While the SynchronyTM RTS delivers a lower
radiation dose to the patient as compared to continuous fluoroscopic imaging, this
is achieved at the expense of intermittent absolute knowledge of internal positions.
TG75 states that the entrance dose per image can be as high as 0.2 cGy.[64] For
a 2 hour session with imaging performed every 30 seconds, the patient receives 48
cGy over the course of the treatment. Alternative image based solutions have been
investigated which utilize the on board imaging (OBI) functionality of many modern
linear accelerators.[6] Similarly to the fluoroscopy based solutions previously men-
tioned, OBI solutions deliver dose to the patient in order to image and track internal
markers/tumors. Another factor limiting this technique is the fact that high energy
MV scatter from the treatment beam can degrade the image quality of the kV im-
ages typically used for tracking.[47] Imaging based methods do have the advantage
of providing information about the surrounding tissue, which a pure electromagnetic
position monitoring solution cannot provide.
Continuous electromagnetic position monitoring is now available without additional
dose to the patient (Calypso Medical, Seattle WA). The system uses one or more
wireless transponders which are subject to performance testing as part of the manu-
facturing operation to ensure they can stand up to high levels of radiation throughout
the treatment process. The transponders are currently implanted into the prostate
via a 14-gauge needle in a procedure similar to existing gold fiducial implants cur-
rently in use clinically. During treatment planning, the location of the transponders
is recorded with respect to isocenter and a plan is developed. During delivery, an
array is placed above the patient. Four source coils in the array excite the transpon-
ders via magnetic induction. After excitation, 32 receiver coils in the array detect
the resulting response signal. Each transponder has a unique resonant frequency, and
they are sequentially exited in order to independently query position information.
The array is registered to the room via stereoscopic infrared cameras, and hence the
transponder position is known with respect to isocenter. Balter et al have reported
submillimeter accuracy when tracking the transponders moving at 3 cm/s in a vol-
ume that is 14x14 cm in width, and up to 27 cm away from the array.[2] In a study
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from Santanam et al the system was again found to be sub-mm accurate as con-
firmed by concurrent onboard kilovoltage imaging.[78] In a clinical prostate cancer
treatment study, Willoughby et al have shown the system to be functional in a linac
environment, even when the linac is treating directly through the array.[108] To date
there have been no published failures of the transponders due to radiation dose. The
system is currently FDA cleared for use in the prostate and prostatic bed. Potential
applications in the lung and abdomen (where motion is substantial) are promising.
In this study, we have investigated the feasibility of using real-time electromagnetic
tracking for linac gating. The system uses a spatial gating technique which gates the
beam via absolute 3D position of the internal fiducials (Figure 2.1) as opposed to
using phase or amplitude like conventional external surrogate systems currently use.
This approach has two primary advantages: (1) the beam is gated off of the internal
position of the tumor as opposed to an external surrogate and (2) it does not require
any additional imaging dose.
2.2 Gating: Latency Estimates
In order to characterize the system initial latency estimates were performed. If the
latency between the time the target leaves the volume to the gating of the linear
accelerator is large when compared with the velocity of the target, this can lead
to substantial dosimetric error. In an initial study to determine the latency of the
system, the signal directly from the dynamic phantom was compared with the “target
current” test-point signal from the linear accelerator using a logic analyzer. Target
current is the current measured at the metal target of the linear accelerator’s electron
beam and hence this signal is analogous to the presence or absence of the treatment
beam. Using the target current as opposed to radiographic methods permits a more
precise measurement of latency using standard test equipment. It also facilitates
acquisition of large numbers of beam transitions for accumulating a histogram of
latencies. The Calypso system was set to monitor positions at 30hz with an update
period of approximately 26ms. Based on this method, a histogram of latencies was
generated over the motion from 200 circular motion cycles (Figure 2.2).
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Figure 2.1: Gating setup. The 4D phantom moves the attached film phantom in
realistic breathing trajectories. Real-time position information of the transponders
implanted in the film phantom are acquired via the array and sent to a decision
making computer. Each position measurement is analyzed to determine whether it
is inside a predefined 3D volume. If so, the beam is turned on and delivery
proceeds. If the position is outside the volume, a Beam Hold is enacted and delivery
halts until the target returns.
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Figure 2.2: Latency histograms for the gating system.
The latencies were broken down into two categories: beam-on latency and beam-off
latency. Beam-on latency is defined as the time duration from target entering gating
volume (as indicated by signal from motion phantom) to first observed target current
pulse on the LINAC. Beam-off latency is defined as the time duration from target
leaving gating volume (as indicated by signal from motion phantom) to last observed
target current pulse on the linac. The mean latencies between transponder position
and linear accelerator modulation were found to be 75.0 ± 12.7 msec for beam-on and
65.1 ± 12.9 msec for beam-off given as mean ± 1 standard deviation (Figure 2.2). The
difference between the beam-on and beam-off times could be attributed to asymmetry
in the LINAC turn-on and turn-off times, or partially due to imperfect alignment of
the phantom with respect to the Calypso gating volume. The range in the latencies
can be attributed to the software implementation of the gating decision unit, as well
as the finite integration times of the transponders (26ms). The latency associated
with enacting a Beam Hold or reestablishing treatment via the linear accelerator
is relatively small, approximately 17 msec [22]. Given the experimental setup, this
value is incorporated into the total latency values reported for the spatial gating
system. Update rates and latencies of the system are comparable to optical [28] and
fluoroscopy [91] based gating systems reported previously.
2.3 Gating: Clinical Dosimetry
In addition, clinically relevant dosimetric analyses were performed. A four field, 6MV,
200 cGy, 3DCRT treatment plan for a random lung cancer patient was selected for
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this study. The treatment plan was developed using Pinnacle version 7.1 (Philips,
Madison, WI) and delivered via a Varian Trilogy linear accelerator. The phantom in
this study was comprised of a standard solid water phantom with one sheet of the solid
water replaced with an equivalently sized acrylic slab containing three electromagnetic
transponders as well as a piece of radiographic film. For each exposure, the film was
placed in the coronal plane. The platform was programmed using respiratory motion
data measured for a lung cancer patient using 4DCT and spirometry (Figure 2.3)
[45].
Figure 2.3: Lung trajectories reconstructed from a 4DCT and spirometry from a
lung cancer patient.[45]
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Figure 2.4: Dose difference maps. Films irradiated in the presence of clinically
relevant motion were subtracted from the static ‘gold standard’ case. A) The entire
dose profile with the ROI indicated via a box.. B) The high gradient region of
interest as denoted by the box in A). C/D) Normalized difference maps were
calculated to show over- and under-dosing as a percentage of maximum dose. Red
and blue regions indicate over and under dosing respectively. Gating reduces the
spread and magnitude of dose mismatch that occurs in the presence of motion.
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Dosimetric films were utilized to determine the dose profile from one fraction of treat-
ment. One baseline run with no motion was used to generate a static film. This film
was used as the ideal dose distribution in the absence of patient motion. The static
film was compared with films irradiated using the same treatment plan delivered both
with and without gating in the presence of motion. Using beam gating, better dose
localization was observed and the film results show better correlation with the static
dose distribution (Figure 2.4). The effects of gating were most evident in the regions
of high dose gradient, as the non-gated case effectively ‘blurs’ the dose over the region
that passes through the isocenter during respiratory motion. Difference maps show
that dose blurring found in the non-gated dynamic case is significantly reduced when
the gating solution is implemented (Figure 2.4). Dosimetric analysis was performed
to quantify the level of over/under dosing. For the no intervention case, 32.1% of
points failed to be within ±10 cGy from the ideal dose and 8.6% failed for ±20 cGy.
For gating, 3.4% failed for ±10 cGy and 0.0% failed to be within ±20 cGy.
Gamma analysis was performed on both the non-gated and gated films. Although
no points failed a 3mm/3% test, 8.3% of the points in the non-gated film failed at
1.5mm/1.5% compared to 0% of the points in the gated film (Figure 2.5).
Figure 2.5: Gamma Maps. Gamma maps for the gated and non-gated cases are
displayed. As described previously, the gamma tool allows for simultaneous analysis
of both distance to agreement and dose difference. Lower values indicate higher
dosimetric agreement.
It is evident in multiple line profiles that gating produces an increase in achievable
dose gradients (Figure 2.6). This increase in dose gradients has clinical implications.
For targets that are close to critical structures, it is ideal to have high dose to the
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target with rapid falloff of the dose to spare the adjacent tissue. Increasing the
achievable dose gradients in the presence of motion ensures better dose conformality
to the target and increases tissue sparing to adjacent tissue. Patient throughput is
a clinical concern. Even when considering the small gating window used for these
preliminary studies, the duty cycle was 47% and 49% respectively for each of the two
lung trajectories. This shows that for most cases the increase in treatment time is
small when compared to the time spent initially aligning the patient and moving the
gantry to the various beam angles. This will not be the case for instances of drastic
motion or when the target leaves the gating volume for an extended period of time.
Figure 2.6: Gating reduces dose blurring and improves dose gradients when
compared to no intervention. Here, dose gradients of line profiles are analyzed for
lines at y=3mm, 8mm, and 13mm (b-d). Raw data is plotted with a polynomial fit
overlaid. It is evident that gating improves dose gradients to match the delivery in
the absence of motion.
14
2.4 Gating: Discussion
Gating is a widely used technique for dose localization. One of the limiting factors
in the effectiveness of gating is that most implementations use external markers to
predict internal movement of tumors. Although studies have shown correlation be-
tween external and internal motion, variations on the order of 1 cm have been found
between internal fiducial motion and external markers.[16, 7] Thus it is important to
implement a solution for determining the precise location of internal anatomy without
exposing the patient to additional imaging dose throughout the course of treatment.
It has been shown that large latencies can produce a phase mismatch between beam
gating and tumor position.[86] For the initial studies shown here, a software based
decision making setup was implemented. For a clinical implementation, a hardware
based solution would offer lower latencies. The latencies associated with our system
are as good as or better than alternative options. For instance, fluoroscopic and op-
tical gating systems claim latencies of 90 ms[89] and 170 ms[28] respectively. Note
that the low latencies associated with our setup demonstrated a measurable dosi-
metric difference without the use of predictive algorithms.[86] This internal tracking
implementation can be incorporated with any linear accelerator in a standard size
vault.
In a clinical implementation the exact dimensions of the 3D gating volume will likely
vary from patient to patient. The 3D volume would be chosen based on a number
of factors: the relationship and level of correlation between the transponder and
the tumor as evidenced via respiratory correlated imaging, the proximity to normal
structures, the amount of target motion, and the desired efficiency of the treatment.
The number of implanted transponders does have an adverse affect on the update rate
of the system. The use of a single transponder increases the acquisition frequency
for the spatial position information, but at the expense of rotational information
obtained via multiple transponders. Studies are needed to determine the cost/benefit
from acquiring spatial information from multiple transponders when compared to the
additional latency associated with multiple transponder readings. For instance, in
a potential clinical implementation multiple transponders could be used during the
patient setup process, but a single transponder localized for gating throughout the
treatment.
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Work is needed to ensure that implantation in the lung is safe. Pneumothorax is a typ-
ical complication with percutaneous implantation of a fiducial in the lung. Although
bronchoscopic implants have lower pneumothorax rates (1.8%)[26] than implants done
percutaneously (33%)[105], additional work is needed to ensure the system is safe for
patient use. Work in developing a bronchoscopic implantation technique for electro-
magnetic transponders is promising.[56]
Additionally, the implanted EM transponders have been shown to be stable in the
prostate case. Targeting of a lung tumor may be more challenging since the transpon-
ders will not likely have a fixed relationship to the lung tumor. Incorporation of the
uncertainty will affect the size of a gating window. Work on a modified transponder
design with stability features shows good fixation to the lung tissue.[56]
If left unchecked, breathing motion prevents high dose gradient regions in which the
delivered dose to the surrounding healthy tissue decays rapidly. High dose gradi-
ents are necessary for dose escalation to tumor sites while ensuring that surrounding
critical structures do not receive substantial dose. As noted in Figure 2.6, the dose
gradients achieved via the gating solution are larger when compared to no intervention
in the presence of motion.
In conclusion, an electromagnetic tracking system has been successfully interfaced
with a linac gating system. The latencies measured were comparable to other real-
time radiation therapy systems, and film experiments using realistic lung trajectories
showed that gating provides significant dosimetric improvements. The aforemen-





Due to the widespread adoption of MLCs for use with conformal and IMRT treat-
ments, it is intuitive and cost effective to implement a motion management solution
relying on already implemented hardware. Dynamic MLC (DMLC) tracking is a
technique that attempts to mitigate the dosimetric error associated with target mo-
tion by updating the positions of the beam-attenuating leaves based on real-time
target position. This technique effectively moves the aperture such that the beam is
continuously centered on the target. This technique alleviates some of the problems
associated with gating. For instance, if a prostate target moves outside of the gating
volume indefinitely due to rectal filling, a gating solution requires the therapist to
enter the treatment room and reposition the patient. At the time of this manuscript,
there has been much published on DMLC tracking [33, 71, 72], however there are
currently no clinical implementations. Additionally, to date all published work on
MLC tracking has relied on external position monitoring, which has associated lim-
itations as noted previously in the Background and Significance section. We intend
to implement an MLC tracking solution in which the beam aperture is moved corre-
sponding to real-time output from the Calypso electromagnetic position monitoring
system. In order to characterize the system latency estimates, geometric accuracy
and dosimetric measurements must be performed.
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3.2 DMLC Tracking: Latency Estimates
There are a variety of factors contributing the latency between target position mea-
surement and MLC response. There is an integration time associated with electro-
magnetic position monitoring. Once positions are acquired, new leaf positions must
be determined based on the new location of the target. Additionally, the leaves have
finite velocities and hence the time required to move into position must also be ac-
counted for. Here we define latency as the time between when the target is at a given
location and the time at which MLC aperture is centered at that location. If the
latency of the system is substantial when compared to the velocity of the target, it
is necessary to implement prediction algorithms in order to maximize geometric ac-
curacy. In an experiment designed to characterize the latency of the DMLC tracking
system, a motion phantom was programmed to move in a sinusoidal trajectory (± 1.5
cm, 15 cycles/min) parallel to the direction of leaf motion. The phantom carried Ca-
lypso Beacon transponders, as well as a steel BB that shows up clearly on Electronic
Portal Imaging Device (EPID) images. EPID images were continuously recorded as
the static prediction window of the DMLC tracking system was systematically varied
for each run from 0 to 250 ms. The EPID images were segmented offline in order
to determine both the location of the steel BB as well as the center of the MLC
defined aperture. The BB location is analogous to the instantaneous position of the
target, and based on the spatial offset between this position and the center of the
aperture the latency of the system was calculated to be 220ms. Target and aperture
trajectories recorded in the absence of motion are shown in Figure 3.1.
3.3 DMLC Tracking: Geometric Accuracy
The geometric accuracy of the system was characterized in a similar manner to the
method used for calculating the latency of the system. EPID images were acquired
and segmented to determine the geometric offset between the target as indicated by
the steel BB and the MLC defined aperture center. For the geometric analysis, the
motion phantom was programmed with the following three trajectories: a respiratory
trace showing high variability, recorded using a dual-fluoroscopic real-time radiother-
apy (RTRT) system [91], a respiratory trace showing moderate variability, recorded
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Figure 3.1: Target (BB) and MLC aperture trajectories in the run recorded with no
prediction. These values were used to calculate the total temporal latency of the
system ( 220 ms). Figure credit Sawant et al. [81].
using the Synchrony system [100] and a prostate motion trace showing relatively
high variability, recorded using the Calypso system [39]. For all geometric accuracy
measurements, the DMLC tracking system was set to update using 220ms predic-
tion. Figure 3.2 shows the geometric accuracy of the system for the aforementioned
trajectories. Accuracy parallel and orthogonal to leaf orientation is characterized
independently due to independent physical limitations of the MLC leaves. The geo-
metric results were evaluated favorably and have been published in a peer reviewed
journal.[81]
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Figure 3.2: Distributions of geometric accuracy for three different motion
trajectories. Figure credit Sawant et al. [81]
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3.4 DMLC Tracking: Dosimetric Accuracy
Even with known geometric accuracy of the system, there remain some clinical ques-
tions regarding implementation. Interplay between the IMRT delivery technique and
tumor motion can lead to dosimetric error [27, 102, 5]. Moreover, the addition of a
motion tracking system to MLC movement during delivery adds complexity to the
therapy quality assurance. Here we intend to investigate the dosimetric effects of
coupling the electromagnetic position measurement guided DMLC tracking system
with IMRT delivery for targets with substantial intrafraction motion and compare
the dosimetric accuracy of this technique with gating via internal position monitor-
ing. Our hypothesis was that an integrated electromagnetic position measurement
- DMLC tracking system should show similar dosimetric results to electromagnetic
position measurement - gating system, but with improved efficiency.
Similar to the previous experiments, the Calypso system was configured to output
3D positions in real-time. The following settings were used for all cases: gantry 90◦,
collimator 90◦, 200 MU delivered via a 6 MV photon beam. The MLC leaves for
both the S-IMRT and D-IMRT plans are aligned in the superior/inferior (primary)
direction of motion. The delivered dose for each plan was approximately 100 cGy at
isocenter. The moving phantom was loaded with a single film aligned in the sagittal
plane at isocenter and irradiated as it moved with two different plans: (1) an S-IMRT
field, and (2) a D-IMRT field. The phantom was programmed with no motion, or
with motion obtained from a lung cancer patient using the CyberKnife Synchrony
(Accuray, Sunnyvale, CA) tracking system [100]. The trajectory had a frequency
of 23 breaths/min and had the following peak to peak amplitudes: 7mm lateral, 23
mm sup/inf, and 6 mm ant/post. The breathing trajectory was relatively periodic,
however not totally uniform throughout the treatment. Dosimetric results in the
presence of motion were recorded for each plan using three different effector systems:
no intervention, DMLC tracking, and a 4mm x 4mm x 4mm spatial gating system.
The comparators for the dosimetric results in the presence of motion were the dose
results obtained with a static target.
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Plan Intervention 3%, 3mm 6%,6mm ±3cGy ±5cGy
Step+Shoot Gating 0.18% 0.00% 10.91% 3.26%
Step+Shoot DMLC 1.21% 0.00% 7.53% 2.73%
Step+Shoot None 2.45% 0.16% 10.86% 5.02%
D-IMRT Gating 0.22% 0.00% 3.30% 0.64%
D-IMRT DMLC 0.24% 0.20% 7.20% 2.02%
D-IMRT None 1.55% 1.09% 13.06% 4.99%
Table 3.1: Dosimetry Failure Rates. Gamma failure rates were reported for all
cases. Note that failure rates for D-IMRT plans were comparable for gating and
DMLC tracking. S-IMRT gating outperformed DMLC tracking. Gating and DMLC
tracking outperformed no intervention in both plans.
Figure 3.3 shows the dose difference maps between the effector systems and the static
‘gold standard’ film. For the S-IMRT case (Figure 3.3a), the DMLC tracking dif-
ference map and gating difference map show similar amounts of mismatch, though
the locations of the mismatch differ. For the single field D-IMRT difference maps
(Figure 3.3b), the gating and DMLC tracking films are comparable. The dose in
the interior of the region is relatively homogeneous, and as a result a difference map
is not the best metric for observing dose artifacts due to motion. In the S-IMRT
delivery, the percentage of points with a difference of ±3 cGy from the static case
were 10.91% and 7.53% for gating and DMLC tracking respectively; for the D-IMRT
3.30% failed for gating while 7.20% failed for DMLC tracking (Table 3.1). Analysis of
the gamma output for 3mm and 3% shows that gating outperforms DMLC tracking
for the S-IMRT case with failure rates of 0.18% and 1.21% respectively (Figure 3.4).
For the D-IMRT case the two intervention methods were comparable, with failure
rates of 0.22% for gating and 0.24% for DMLC tracking (Table 3.1). Both methods
of intervention outperform no intervention with failure rates of 2.45% and 1.45% in
the presence of motion for the S-IMRT and the D-IMRT plan.
3.5 DMLC: Tracking: Efficiencies
In addition to dosimetric accuracy, the delivery efficiencies were recorded for each
case. The ‘Beam-On Time’ and ‘Total Time’ displayed on the console of the linac
were recorded for each delivery. These metrics are used to determine the efficiency of
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Figure 3.3: Difference maps were produced after registering the dose profiles in the
presence of motion with the film obtained via static delivery (the ‘gold standard’).
The control from runs in the absence of motion are given as a reference in each case.
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Figure 3.4: Gamma values were calculated for each of the moving images. The
values for the distance to agreement criterion ∆d= 3mm and the dose agreement
criterion ∆D = 3% of the maximum dose. The control runs in the absence of
motion is given as a reference for each case.
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Beam On Total Time Duty Cycle
Plan Intervention Time (min) (min) (Normalized)
Step+Shoot Gating 0.30 1.68 38%
Step+Shoot DMLC 0.32 0.60 100%
Step+Shoot None 0.32 0.64 100%
D-IMRT Gating 0.30 0.53 22%
D-IMRT DMLC 0.32 0.36 100%
D-IMRT None 0.33 0.35 100%
Table 3.2: Efficiency Values. Delivery efficiencies were recorded in the form of Beam
on Time and Total Time for each of the delivery conditions. Values along with
associated duty cycles are reported. The duty cycle values are normalized to the
static delivery case (100% indicates no efficiency drop due to intervention).
delivery for each effector system. Delivery without intervention requires Beam Holds
as the leaves in the MLC move from position to position. Our metric for efficiency
uses a normalized duty cycle in which 100% matches the efficiency of delivery without
intervention. Results show that DMLC tracking provides for drastic improvements
in delivery efficiency when compared to beam gating (Table 3.2). DMLC tracking
and beam gating showed duty cycles of 100% and 38% when delivering the S-IMRT
plan. In addition DMLC tracking outperformed gating in the D-IMRT plan (100%
and 22% respectively). The dosimetric and efficiency results have been published in
a peer reviewed journal.[96]
3.6 DMLC: Tracking: Discussion
We have successfully implemented a tracking system that does not rely on ionizing
radiation or an external tumor surrogate for the detection of internal targets. The
DMLC tracking solution shows promise for the reduction of motion-related dosimetric
errors. However there are several details that still need to be addressed. For the case
of the D-IMRT plan, the gating solution produced comparable dosimetric output
when compared with the DMLC tracking. The D-IMRT plan shows relatively few
high dose gradient regions in the center of the dose distribution. As a result, in the
interior of the target the dosimetric errors associated with superior inferior motion
are not as evident from a difference map.
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The S-IMRT delivery to the moving phantom with no intervention corresponds to a
convolution of the beam profile for each step-and-shoot segment with the motion of
the phantom during delivery of that segment. With gating, the delivery corresponds
to a convolution with the residual motion within the gating window. Therefore, one
would expect small blurring of the dose profiles with dosimetric errors related to the
size of the gating volume. The errors associated with DMLC tracking are not as lucid.
Here, the discrepancy with the static case is caused by failure to align instantaneously
to the target position and the coarse (one leaf width) aperture resolution orthogonal
to the leaf direction. It is possible that the target motion oscillated in a fashion that
dictated a shift back and forth of one leaf position in the anterior/posterior direction,
this could lead to substantial dosimetric error on the order of the size of the 1 leaf (5
mm). It should be noted that our algorithm did not use subleaves to estimate motion
orthogonal to the leaf direction.[82] As a result, a shift in the anterior/posterior
direction is ‘all or nothing’ which could have potentially led to the dosimetric error
seen in the S-IMRT DMLC tracking films.
It is notable that increased efficiency has potential for dosimetric implications, not just
patient throughput. If the patient is on the table considerably longer (e.g. when using
a very small gating window), it is possible the patient will move due to discomfort.
Though not in the scope of this experiment, this motion has potential dosimetric
consequences.
There is further work to be done on the system. Currently there is variable latency in
the position monitoring which is not taken into account by the prediction algorithm.
Setting a fixed latency for the position monitoring, or accounting for the variable la-
tency in the MLC tracking algorithm would provide for better geometric (and hence
dosimetric) results. In addition, reducing the overall latency of the system as a whole
would provide for better dosimetric results. Incorporating target deformation and ro-
tation into the beam shaping is another potential improvement for the system. Work
needs to be done to evaluate a variety of treatment plans to ensure the MLC track-
ing algorithm is robust and accurate when applied to any conventionally generated
treatment plan.
There are plans for commercialization of this system. It may be safer to implement
the system for prostate cancer management, since there are currently approved uses
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for Calypso Beacon implantation for that location. Further uses, such as lung tumor
tracking, will need a new transponder design that can be safely inserted in the thorax.
It is not clear whether changes in treatment planning software will be necessary,
though they may be desirable to fully take advantage of the DMLC tracking capability.
The tools for quality assurance of the system will have to be developed, and may
include motion phantoms such as the one used in this work. Safety and reliability of
a commercial implementation will have to be investigated in a more thorough manner
than this preliminary work.
In summary, we have integrated a system that senses real-time internal anatomy
positions without the use of ionizing radiation with a DMLC tracking system to
deliver continuous dose to a moving target. The dose profiles are comparable with an
internal gating solution, eliminate the uncertainties inherent in the use of chest wall
surrogates for tumor position, and show much higher delivery efficiencies with the
promise of increased clinical confidence in the delivered dose. More work is left to be
done in further improving the dosimetric results in an effort to create a system that
delivers accurate radiation with sub millimeter intrafraction motion management, as





4.1 Fiducial Correlation: Motivation
Radiation therapy often relies on fractionated treatment, which requires repeated pa-
tient positioning. Motion associated with respiration can be on the order of centime-
ters. For targets in the lung and abdomen, respiratory motion complicates accurate
radiation delivery.
In order to mitigate the effects of motion, external surrogates have been employed to
monitor the breathing cycle and ‘gate’ the beam such that it only irradiates during
exhalation. While these surrogates offer a noninvasive option for motion management,
the degree to which external respiratory surrogates reflect internal tumor motion
varies.[13, 7, 16]
Recent work has shown that implanted fiducial tumor surrogates are safe and stable
throughout the course of treatment. In a study from Kupelian et al, CT imaging
was used to assess the proximity between an implanted metal fiducial and the GTV
centroid throughout the course of treatment.[40] The average 3D variation in the
GTV center relative to the marker was 2.6mm, with all cases <5mm. Although
tumor shrinkage was apparent as a result of radiation, fiducials in or near tumors
were relatively stable throughout treatment. Additionally, there was no incidence of
pneumothorax in the 6 patients that underwent transbronchial implantation.
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Real-time applications using internal fiducials as analogues for tumor motion have
been developed, and the use of implanted fiducials in or near a target of interest has
seen widespread adoption for daily patient alignment.[91, 39, 108] We have previously
published use of wireless electromagnetic transponders (Calypso Medical, Seattle WA)
for radiation therapy to increase dosimetric accuracy in the presence of respiratory
motion.[95, 96, 81] The transponder positions with respect to isocenter are continu-
ously monitored in real-time using electromagnetics. In an initial study, the real-time
internal fiducial position was used to gate the beam.[95] In later studies, the beam
aperture was effectively ‘moved’ using dynamic multileaf collimator (DMLC) tracking
in order to follow the real-time position of a transponder.[96, 81]
The Cyberknife Synchrony system and the ExacTrac X-Ray 6D IGRT system (Brain-
LAB) rely on stereoscopic X-ray imaging in order to determine the position of an
internal fiducial in real-time.[83, 63] A correlation model developed at the start of
treatment relates the internal fiducial motion with respect to infrared markers at-
tached to the patient’s surface. Intermittent imaging is employed to confirm and
continually update the correlation model. Using this position, the beam is moved
using a robotic arm or gated in order to mitigate the effects of respiratory motion.
The degree to which the motion of an implanted lung fiducial marker correlates with
the motion of a tumor typically deteriorates with increased implantation distance be-
tween the fiducial and the tumor. It has been shown that increasing the proximity be-
tween an external respiratory sensor and internal target increases the correlation.[36]
Similarly, increasing the distance between an implanted fiducial and the target has the
potential to increase the error resulting from deformation between the fiducial/target.
For fiducials in the lung, bronchoscopic implantation is typically favored over percu-
taneous implantation due to the reduced risk of pneumothorax.[40] Distal airways
are smaller in diameter and limit access to peripheral lesions, which typically exhibit
large amplitudes of motion ( 1-4 cm). As a result, the proximity of the internal
transponder and the target of interest is limited by the bronchial tree structure.
While the previous studies have investigated the overall fixation of an internal marker
for lung tumor tracking, there has not been a quantitative assessment of how close a
fiducial marker must be placed with respect to a tumor in order to ensure accurate
motion representation. We intend to investigate the level at which an implanted
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internal fiducial can predict the intrafraction motion of surrounding anatomy within
the lung. This knowledge will increase the confidence of the fiducial-based intervention
systems and potentially allow for decreased PTV margins, sparing healthy tissue.
4.2 Fiducial Correlation: Methods
4.2.1 Dataset and Techniques
Ten randomly chosen primary lung cancer patients underwent 4DCT scans in the
supine position. The scans were performed using a Philips Brilliance 16 slice CT
scanner (Philips Medical Systems) that was operated in cine` mode with a stationary
couch during the scan. The axial slice thickness was set at 1.5mm, which yielded a
total thickness of 24mm for each couch position (16 slices x 1.5mm/slice). For each
axial slice, 25 images were acquired over the course of two to three breathing cycles.
Respiration was monitored using spirometry and a pneumatic bellows pressure sensor
attached to the patient’s abdomen.[46] Each acquired image was synchronized with
a corresponding tidal volume as measured by respiratory monitoring devices. The
4DCT scans were reconstructed at maximum inspiration and maximum expiration
using amplitude-based reconstruction techniques described previously.[44] The deci-
sion to use only maximum inspiration and maximum expiration phases was based on
the fact that previously published results have shown that hysteresis derived motion
is typically less of a factor than tidal volume related motion.[113]
Each 4DCT dataset was imported into clinical treatment planning software (Pinnacle
v. 8.0u, Philips Medical). The tumor and four main lobes of the lung (right/left
upper/lower) were contoured at exhalation. The right middle lobe was not contoured
due to its lack of size. Both inhalation and exhalation scans, along with the contours,
were exported and loaded into custom software developed in MATLAB (2007a, The
MathWorks) in order to perform deformable registration.[110]
Deformable registration was performed using the Horn-Schunck optical flow algorithm[24]
in order to obtain motion vectors between exhalation and inhalation for each voxel
within the thoracic cavity. After the vectors were obtained for each patient, they were
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manually inspected to ensure the vector magnitude increased near the diaphragm and
the motion vectors matched with the motion of internal high contrast landmarks, such
as bronchial branch points. Each scan was reviewed in detail by one of the authors
[RS].
Once the vectors were manually verified, two studies were performed. In the first
study, a series of regularly spaced ‘seed points’ (every 4th voxel. 4mm spacing lateral
and anterior/posterior with 6mm spacing superior inferior) throughout each lobe were
selected to determine the degree of correlation with surrounding tissue motion. In
the second study, ‘tumor-centric’ analysis was performed to evaluate the effects of
increased rigidity associated with cancerous tissue on motion vector correlation in
areas surrounding a tumor.
4.2.2 Correlation Radius
A region growing algorithm was employed to determine the maximum radius at which
the magnitude of the vector motion of 95% of the voxels surrounding a seed point
correlated to within 3mm of the motion of the seed voxel. The technique for the
correlation radius analysis is outlined in Figure 4.1. A seed point array with 4mm
spacing in the lateral and anterior/posterior directions and 6mm spacing in the su-
perior/inferior directions was analyzed. For each seed point, the region-growing al-
gorithm expanded radially with an increment (∆r) of 1mm. After each iteration, the
exhalation to inhalation motion vectors within the spherical region surrounding the
seed point were compared to the motion of the seed voxel. If the motion vector for
a given voxel correlated to within the spatial threshold (3mm) when compared with
the motion of the seed voxel, the voxel was considered accepted via our criteria. The
spherical region expanded to the maximum radius value at which 95% of the voxels
within the region correlated to within 3mm. Voxels not within the same lung lobe as
the seed voxel were disregarded.
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4.2.3 Tumor Correlation
In order to quantitatively analyze whether the increased rigidity associated with can-
cerous tissue affects the surrounding tissue correlation, the volumetric centroid of the
tumor was selected as the representative tumor motion vector. This vector represents
the offset of the tumor between maximum exhalation and maximum inhalation. The
motion vector from the tumor centroid was compared with the motion vectors of all
surrounding tissue within the lungs. If it is assumed that a given voxel moves in a
rigid manner with respect to the tumor centroid, this difference effectively represents
the intrafraction motion error if a fiducial was placed at that voxel. Differences in
the tumor motion vector and the surrounding tissue were plotted using color overlays
indicating the motion correlation of surrounding tissue motion with that of the tumor.
Figure 4.1: Correlation Radius Technique: Lung lobes and tumor were contoured at
expiration (1). Deformable registration was performed between inhalation and
exhalation CT scans to obtain motion vectors (2). Seed points were selected at
random, ten per lung lobe (3). A spherical region growing algorithm was employed
to determine the maximum radius at which 95% of the surrounding voxels
correlated with the seed voxel motion (4).
32
4.3 Fiducial Correlation: Results
4.3.1 Motion Correlation: General Lung Results
Correlation radius values were obtained for each patient. In one patient (35), the
motion within the right upper lobe was minimal and hence the vectors correlated
to within 3mm regardless of seed point position. The radius values for this patient
were set at the maximum radius value (7cm). The mean correlation radii for each
lobe are shown in the Table 4.1. Additionally, histograms of the radii values for
each lobe can be found in Figure 4.2. Tumor correlation radii values were found to
be higher than those of healthy lung tissue (p<0.005) indicating that the increased
rigidity associated with cancerous tissue makes surrounding lung tissue motion highly
correlated. Additionally, the upper lobes were found to have radii values significantly
higher than the lower lobes (p<0.005).
Lobe Mean (std)
Left Lower 1.7 (1.1)
Right Lower 1.6 (1.1)
Left Upper 2.1 (1.0)
Right Upper 2.9 (1.8)
Tumor 3.1 (1.8)
Table 4.1: Correlation Radius Values. Correlation radii values to represent 3mm
motion. Means and standard deviations are reported for each lobe in units of cm.
Tumor correlation radii were significantly higher (p<0.005) than the healthy lung
tissue radii values.
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Figure 4.2: Histograms of correlation radii values for each lobe. Notice increased
correlation radii values for the upper lobes when compared to the lower lobes.
Correlation radii values were capped at 7cm, which resulted in the 7cm peak in the
low motion Right Upper lobe.
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Correlation maps were made for each patient (Figure 4.3). The maps show a coronal
and sagittal view take at the carina and middle of the left lung respectively. For each
map, the interpolated correlation radii for each voxel are overlaid. The correlation
with surrounding tissue varies substantially with position and is inversely related to
the divergence of the motion vector field (Equation 4.1).
~T ∝ (5 · ~M)−1 (4.1)
where
~T = Surrounding Tissue Correlation
~M = Motion Vector Field
Correlation radius maps were made for each patient. The background of each map is
a coronal slice containing the carina as a reference landmark. The centroid of each
circle overlay is the location of the seed voxel. The radius of each circle overlay is the
maximum correlation radius for each given seed voxel (Figure 4.3). It is evident that
there is considerable patient to patient as well as lobe to lobe variation in correlation
radius.
4.3.2 Motion Correlation: Tumor Centric Results
Correlation values between the volumetric centroid of the tumor and the surrounding
tissue were calculated. The correlation with surrounding tissue is plotted in Figure
4.4. Variations in tumor motion correlation with surrounding tissue are evident due
to local variations in the divergence of the motion vector field. Tumor motions ranged
from 1.6mm to 12.0mm with a mean motion of 6.0mm across all patients.
4.4 Fiducial Correlation: Discussion
It is evident that the radius at which surrounding tissue motion correlates with an
internal point within the lung is highly variable both from patient to patient as well
35
Figure 4.3: Correlation Radii Maps. Regularly spaced voxel within the lung were
analyzed using the process described in Figure 4.1. Correlation maps were produced
to display how well the anatomy correlates with adjacent anatomy within the
thoracic cavity. Red indicates low correlation with surrounding anatomy motion,
blue indicates high correlation.
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as from point to point within a single patient. As a result, clinical decisions such as
reducing PTV margins due to an internal fiducial based motion management solution
should account for both the error associated with the tracking system, as well as the
error associated with tumor/fiducial correlation.
As deformable modeling techniques and computing power improve, a potential imple-
mentation could incorporate real-time deformation between the tumor and respiratory
surrogate at time of treatment. However, given other uncertainties which contribute
to increased margins such as lack of robust knowledge of what surrounding tissue is
potentially harmful as well as daily alignment and changes in internal morphology, it
is likely that considerable time will pass before real-time deformable intervention is
clinically implemented. As a result, focused efforts on obtaining a patient by patient
routine for determining rigid correlation between internal targets and implanted fidu-
cials will provide confidence in fiducial-based treatment delivery for mobile targets.
Deformable registration techniques are computationally intensive, however in practice
they can be automated to a large extent. Additionally, although computation time
is a concern, on order the registration and region growing algorithm presented here
take less than the amount of time associated with conventional D-IMRT planning.
A system in which the data from a 4DCT scan is loaded into a software package,
deformable registration is automatically performed (possibly overnight using tradi-
tionally idle computational resources), and correlation maps such as those in Figure
4.4 are presented to the physician could provide useful feedback in treatment deci-
sions.
A general rule on where to implant with respect to the tumor was not established.
Typically tissue motion correlation deteriorates when moving in the superior/inferior
direction. This is usually the largest component vector of respiratory motion and
generally has the largest divergence of the vector field. This relationship was not
the case for many of the patients found in Figure 4.4. In summary, internal motion
correlation is highly patient specific as well as specific to the lobe within the lung
based on the breathing patterns for a given patient.
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Figure 4.4: Correlation Tumor Maps: Motion correlation values were observed with
respect to the tumor centroid (indicated by white point). It is evident that
correlation is variable based on the divergence of local motion vectors.
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Chapter 5
Lung Image Guided Surgery
5.1 Introduction
Advancements in surgical intervention have drastically improved outcomes as well as
minimized the complications associated with invasive procedures. Effort has been
made to minimize the trauma associated with surgical procedures by incorporating
technology. Decreasing the invasiveness of surgery has the potential to result in
increased survival rates, fewer complications as well as a reduced recovery time prior
to returning to normal healthy life.
The advent of minimally invasive technologies has impacted medical practice from di-
agnostic to interventional procedures. Image guided surgery (IGS) offers the physician
alternative imaging approaches during surgical intervention. Currently, commercial
IGS products focus on neurosurgery[18], orthopedic[61] and otolaryngologic[19] ap-
plications. A surgical system that could reduce trauma for procedures within the
thorax and abdomen is appealing.
Procedures in the lung/abdomen that would benefit from IGS include radio frequency
ablation (RFA), lung biopsies, as well as brachytherapy seed placement. In RFA, ra-
dio frequency energy is imparted through a catheter to ablate a tumor. RFA offers
local heating from inside a tumor, assuming the guidance system to get the catheter
in the proper location is sufficiently accurate. As a result, this modality has the po-
tential to reduce trauma to adjacent healthy tissue when compared with conventional
external beam stereotactic radiotherapy. Currently, RFA is not routinely clinically
implemented in the lung, however procedures in the heart and liver are routine.
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The use of needle biopsy techniques is widespread in efforts to determine malig-
nancy of lesions within the lung. In order to guide the physician, imaging techniques
such as computed tomography (CT) and fluoroscopy are routinely employed. Even
when using advanced imaging techniques, the diagnostic accuracies of needle biop-
sies are poor when the lesions are small.[101, 42] Li et al report a drop in diagnos-
tic accuracy from 96% to 74% when comparing nodules of diameter >1.5cm and
≤1.5cm respectively.[42] Tumors have been shown to move at amplitudes >1cm due
to respiration;[50, 99] failure to account for this motion will lower biopsy accuracy
rates, especially for smaller lesions. As a result, many institutions currently will not
attempt to biopsy lesions less than a centimeter in diameter. Creating a system capa-
ble of sufficient accuracy to biopsy small lesions could provide the potential for early
detection. Early detection has shown to be a key factor in survival rates. Henschke
et al report early diagnosis of Stage I lesions resulted in a five year survival rate of
90%, compared with patients diagnosed with Stage III or IV lesions which have 5
year survival rates of 15%.[23]
Finally, brachytherapy seed placement could benefit from an accurate respiratory
correlated guidance system. In brachytherapy, a radioactive source is placed inside
of the body in order to irradiate a tumor. This allows for more localized radiation
and sparing of healthy tissue, however it is reliant on accurate placement of the seed
source. As a result, the procedure has conventionally been limited to percutaneous use
in the prostate, cervix, and breast. Brachytherapy has been used in the lung, however
it has been limited to intraoperative use due to the imprecision of percutaneous or
bronchoscopic seed placement in the presence of motion.
There are some current commercial minimally invasive lung guidance systems. The
superDimension InReach system provides a minimally invasive means for broncho-
scopic lung biopsies. The system relies on electromagnetic position monitoring of
a catheter inserted through the working channel of a bronchoscope. Registration
between a priori acquired CT or MRI images and the room coordinate system is per-
formed by advancing the bronchoscope down several pathways. The EM coordinates
in doing so are then compared with the pathways on the autosegmented volumetric
imageset. During a procedure, the bronchoscope is advanced until it cannot continue
due to the width of the surrounding bronchiole. From here, the EM catheter and
surrounding guide sheath are advanced without the use of real-time bronchoscopic
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imaging. The position of the catheter tip is shown on the previously acquired volu-
metric images. The catheter is mechanically steerable, and the position of the distal
tip is updated in real-time on the computer console. Once in the correct location,
the guide sheath surrounding the catheter is left in place, the catheter is removed
and bronchoscopic tools are employed to gather tissue samples. The superDimension
is novel in that it provides minimally invasive access to distal sites conventionally
unreachable by a bronchoscope, however there are some limitations. The system does
not attempt to account for tissue motion due to respiration. Additionally, the pub-
lished accuracy results for the system are limited to the spatial accuracy of the EM
tracking system. This fails to address the spatial accuracy of intervention in a human,
which has inaccuracies related to registration and respiratory motion.
The Philips PercuNav system uses EM tracked instruments along with real-time ul-
trasound registered to a priori acquired volumetric images. It offers automated reg-
istration of the real-time ultrasound images to the volumetric imagesets via tracking
the ultrasound probe in 3D. The PercuNav system does have some rudimentary res-
piratory gating capabilities, however there is no real-time modeling of the tumor
trajectory for intervention in the lungs.
The StealthStation Treon system from Medtronic Navigation is routinely used in
craniospinal minimally invasive procedures. Similar to the previously mentioned sys-
tems, this system uses electromagnetic navigation over a priori acquired volumetric
images. The system is widely used in cranial applications, however it is currently not
for clinical use in the lungs or abdomen. The StealthStation offers two methods for
registration. In point based registration a series of CT contrast markers are defined
both on the CT image and in the room coordinate system by systematically touching
the EM tools to each point. Alternatively, tracer based registration relies on tracing
a known structure such as the bridge of the nose and forehead using an EM tool, and
the acquired points are automatically matched to the autosegmented skull surface
in the CT image. Once registration is performed, the system shows the position of
the catheter in real-time, however there is currently no motion model for respiratory
correlated IGS. More information on the StealthStation is included in Appendix B.10
We incorporated previously published tissue modeling[45] based on respiratory corre-
lated imaging (4DCT) in an effort to develop an IGS system that accounts for target
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motion and improves the accuracy of minimally invasive needle biopsy techniques in
the lung. A temporal guidance and planning system was developed and the accuracy
of the system is characterized in phantom, ex-vivo porcine and human cadaver set-
tings. The system works in conjunction with a Medtronic StealthStation, provided
to [RS] as part of a computer aided surgery grant from Medtronic Navigation.
Figure 5.1: Medtronic StealthStation. The field generator (black, foreground) and
the Medtronic StealthStation (background) are shown. A position sensitive
magnetic field is generated with respect to the field generator, which allows for
precise location monitoring of EM tools in the tracking volume.
5.2 Methods and Materials
A commercially available IGS solution (StealthStation) was employed in order to
track the tips of interventional tools via electromagnetics. A field generator con-
nected to the StealthStation creates a position dependent magnetic field inside of the
patient. The system uses tools with two copper wire coils near the tip that act as
inductors. Based on the amount of current induced in the coils of the tool from the
surrounding magnetic field, the positions of the AxiEM tools are known to sub-mm
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accuracy in three dimensions (Figure 5.1). The respiratory correlated image guided
surgery (RCIGS) system consists of additional software that communicates with the
StealthStation via application programming interfaces (APIs). The RCIGS system
works in conjunction with the StealthStation to offer temporal guidance to the physi-
cian for intervention on moving targets. The RCIGS surgical guidance planning and
intervention is described in Figure 5.2.
5.2.1 RCIGS System Overview
4DCT acquisition
A respiratory correlated imaging technique (4DCT) using a commercial CT scanner
(Philips Brilliance 64 or Philips Brilliance Big Bore 16 depending on availability) was
employed to obtain a series (n=4) of volumetric images, each of which correlate with
a specific phase/amplitude of the breathing cycle as indicated by a respiratory sur-
rogate. The respiratory surrogate used was a pneumotachograph (Figure 5.5) which
provides an accurate, calibrated representation of tidal volume and airflow throughout
the image acquisition. The imaging mode was retrospective helical reconstruction,
with a voltage of 120kVp and current of 133mAs.[65] For more information on the
details of 4DCT acquisition, please refer to Appendix B.2
Target Position
After 4DCT imaging, the reconstructed DICOM images are network transferred to
a research system containing Philips Pinnacle (version 8.1y). Pinnacle is a clinical
radiation therapy treatment planning software package which offers a robust envi-
ronment for manual image segmentation and contouring. Targets were defined using
a lung viewing window (W:1600, L:-600) and their position centroids recorded on
each of the volumetric images from the 4DCT. This provides a location of the target
based on the signal from an external respiratory surrogate. At the completion of this
stage, 4 target locations are available with corresponding tidal volume and airflow
measurements from the respiratory surrogate.
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Figure 5.2: Lung IGS Workflow. 4DCT images are acquired based on a respiratory
waveform from a pneumotachograph connected to the patient’s mouth piece. The
4DCT images are sent to the RCIGS planning software, as well as a contouring
workstation for target definition with respect to respiratory phase. The
StealthStation receives entry and target points from the RCIGS planning software,
the exhalation CT, and the real-time tool position via EM position monitoring. The
StealthStation offers real-time visual guidance to the physician on the location of
the needle tip inside the patient. Four target points with respect to respiratory
phase are sent from the Pinnacle workstation to the 5D model computer. The
model parameters (α/β) are input to the RCIGS guidance software, along with the
real-time respiratory waveform. From here, the RCIGS guidance software
determines the position of the target in real-time, and indicates the proper time for
intervention to the physician via auditory and visual feedback.
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Model Calibration
The 4 target positions along with tidal volume and airflow measurements are used
to calibrate a previously described model for respiratory motion. In short, the model
is parameterized via the 4 known target positions and at completion the model can
accurately predict with the position of the target at any tidal volume and airflow rate
in real-time. The details of the model are not included here for the sake of brevity,
but can be found in previously published work[45] as well as Appendix B.2.
Surgical Plan
Once the target position is known for any tidal volume and airflow, a location and
time of intervention is selected. The location should attempt to maximize the time
at which the target is relatively stationary and respiration is reproducible. This
typically occurs at exhalation. Once the entry and target points for the plan are
selected, custom software displays the motion of tissue within the lung to ensure
critical structures do not move into the surgical path as a result of respiration (Figure
5.4).
The planning software was written in C++ using the following open source libraries:
the visualization toolkit (VTK) for image processing and visualization, the insight
toolkit (ITK) for image segmentation and registration and the Fast Light Toolkit
(FLTK) for graphical user interface (GUI) generation. The aforementioned toolkits
provide a framework for reading and manipulating 3D medical image datasets without
programming the low level functions for image interaction in C++. This allowed for
rapid deployment of software without solving tedious computer science problems that
have previously been investigated. The relation in which the frameworks are employed
is displayed in Figure 5.3
The RCIGS planning software displays the trajectory of the needle tip with respect
to the motion of the tissue due to respiration. In order to achieve this goal, a 4DCT
dataset consisting of a series (4-10) of 3D volumetric images is loaded from the hard
drive into RAM. The memory required for this task is approximately 1.5GB, which is
available on currently affordable consumer computers. The CT images are displayed
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using three orthogonal views. Once the 4DCT datasets are loaded, the trajectory
of the tooltip is overlaid. The approach trajectory can be modified if it interferes
with critical structures. The motion of the tissue due to respiration can be simulated,
and the software loops through the various phases of the 4DCT while updating the
displays in real-time. This allows for evaluation of critical structure motion due to
respiration, and the path to the target can be modified accordingly. The software
also has basic window/level functionality available in most image display software in
order to increase contrast depending on the region of interest within the body.
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Figure 5.3: RCIGS Software Architecture. The RCIGS package is built on open
source software libraries. The libraries provide a means for segmentation,
visualization and fast data manipulation in C++. The Visualization Toolkit (VTK)
and Insight Toolkit (ITK) packages rely on commonly used lower level techniques
and libraries such as the GDCM (DICOM image reading/writing), OpenGL
(computer visualization), and VNL (numerics)
Figure 5.4: Lung IGS Planning Software. Target, entry and approach trajectories
are visually displayed along with respiratory correlated imaging. This allows the
physician to determine whether critical structures enter the approach path as a
result of respiration prior to surgical intervention.
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Surgical Guidance
Figure 5.5: Pneumotachograph. A
pneumotach head (A, side profile: F) is
attached to a custom fabricated circuit
board. The board offers voltage output
corresponding to raw air flow (B) after
analogue low pass filtering (C).
Additionally, there is on-board analogue
to digital conversion and encoding (D) in
order to interface via a serial port (E)
with a Philips Brilliance CT scanner.
Once the surgical plan is established;
part of the RCIGS software package
(Figure 5.6) guides the physician on
when to perform the intervention. The
position of the target is known in real-
time based on the signal from the respira-
tory surrogate, and the target position is
displayed to the physician. Additionally,
visual and auditory feedback are given
when the target is within a predefined
volume. This allows the physician to ad-
vance the needle and/or perform the tis-
sue resection when the target is in the
appropriate location. Due to the lim-
its imposed by human motor skills, in-
tervening on a point static in space at a
time in which the target is at that loca-
tion is more accurate attempting to fol-
low the target with the needle as it moves
through the entire range of motion.
The real-time guidance software was de-
veloped in C# using National Instru-
ments Measurement Studio for data ac-
quisition and display. Measurement stu-
dio provides a series of .NET libraries
and classes for building measurement
and automated display applications us-
ing Microsoft Visual Studio. A pneumo-
tachograph was employed to obtain ac-
curate tidal volume and airflow measure-
ments. The device consists of a chamber
with several small capillaries designed to ensure the flow between the entrance and
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exit is laminar (Figure 5.5). The pressure at the entrance and exit is fed to a dif-
ferential pressure transducer. This pressure differential is proportional to the flow
through the device. Low pass filtering is done to get rid of high frequency noise, and
efforts were made to minimize the drift in the circuit over time. The board offers on-
board analogue to digital conversion and encodes the respiratory signal in a manner
to directly communicate with a Philips Brilliance CT scanner. The electrical circuit
used for the board was based on a schematic from an industry partner, and as a
result the circuit is not included here. The board offers raw voltage output to a data
acquisition board (DAQ) connected to a PC with the real-time guidance software.
The software acquires and displays the respiratory tidal volume signal in real-time.
Additionally, the software shows the position of the moving target with respect to
the static location of intervention in real-time based on the previously calibrated 5D
model.
Figure 5.6: Lung IGS Intervention Software. The respiratory waveform is displayed
to the physician. Binary auditory and visual feedback is given to the physician
when the target is within a predetermined range. The static intervention target is
shown as a yellow dot with multi-plane views. The position of the red dot changes
in real-time based on the previously calibrated 5D model indicating the target
position as a function of the respiratory surrogate.
The pneumotach was calibrated using a precision machined 600 ml syringe to inject
a known volume of air through the device. A series of 10 inhalation/exhalations
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were performed to determine the reproducibility of the pneumotach for a known tidal
volume. The calibration waveform is displayed in Figure 5.7. Peak detection was
employed to obtain standard deviations at inhalation (1.6%) and exhalation (0.2%).
These variations are suitable for highly accurate respiratory motion modeling, and are
likely a result of nonlinearities present at the beginning and end of manually pushing
the syringe.
Figure 5.7: Pneumotach Calibration. A pneumotachograph was constructed to
obtain highly accurate tidal volume recordings. The calibration waveform was
obtained using a 600ml syringe. Standard deviations were obtained at inhalation
(1.6%) and exhalation (0.2%) using peak detection.
5.2.2 System Accuracy: Overview
In order to develop the RCIGS system and obtain quantitative measurements of the
overall accuracy, a series of experiments were designed with increasing difficulty. Mo-
tion phantom, ex-vivo porcine, and human cadaver models were successively employed
and each stage had an associated criteria for success. An overview of the success cri-
teria and problems that each model attempted to address is included in Figure 5.8,
with details on each model found in Sections 5.2.3, 5.2.4, 5.2.5 respectively.
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Figure 5.8: System Accuracy Models. The RCIGS system was tested in robotic
phantom, porcine, and human cadaver environments. The table outlines the
problem each model attempted to address, as well as a quantitative success metric.
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5.2.3 System Accuracy: Phantom Assessment
A robotic motion phantom (Washington University 4D Phantom)[52] was used to
initially characterize the accuracy of the system. The goal of the motion phantom
study was to characterize both the target motion modeling portion of the RCIGS
package, as well as the intervention on a moving target by a surgeon. The phantom
was programmed to reproduce the motion from a lung trajectory recorded via an
implanted position-monitoring device (Beacon, Calypso Medical) in the lung of a
human patient.[56] The arm had several radiopaque markers (IZI Medical MM3005)
affixed that are readily apparent on CT imaging. A 4DCT image was acquired of
the motion phantom as it moved, which was subsequently used for model calibration
and intervention planning according to the RCIGS system. (5.2) Since the original
trajectory is known, it is possible to compare the output from our model to the
actual trajectory. This was performed both for the entire trajectory as well as for the
portion of the trajectory at exhalation, which is when the surgical intervention occurs.
Criteria for model calibration success was a mean error of <1mm at exhalation, which
allows for additional errors associated with positioning the probe, registration, and
motion while still allowing for our goal of 1cm lesion intervention.
Point based registration between the CT image and surgical room coordinate system
was performed by using an EM tool to touch several radiopaque markers affixed
to the phantom arm, and defining the same positions inside of the StealthStation
software on the CT image. An EM ‘patient tracker’ sensor was affixed to the non-
moving base of the phantom. This sensor offers a coordinate transformation and
ensures the registration is accurate even if the ‘patient’ moves with respect to the
field generator. Since the target exhibits motion, it was necessary to know both the
location of the surgeon’s tool as well as the location of the phantom arm at the time
of simulated intervention. Two electromagnetic tools (AxiEM) were used. One probe
was handled by the surgeon performing the intervention [RS], while the other was
affixed to the phantom arm to provide the position in real-time as the phantom moved.
The phantom arm was hidden from view leaving the surgeon reliant on the guidance
software provided from the StealthStation along with the RCIGS package to perform
the intervention. Additionally, a static offset was used when selecting a target point
such that there was no physical contact between the motion arm and the intervention
tool. The motion phantom was programmed to run the same trajectory used during
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imaging. When the target/tool were in the correct location as indicated by the RCIGS
software, the surgeon simulated intervention by depressing a footswitch. At this
time the RCIGS software communicated via TCP/IP over an ethernet link with the
StealthStation to obtain the position of both EM tools. The positions (n=25) of the
arm and intervention tool were simultaneously recorded for error analysis. Criteria
for success were 3D errors between the tool tip and the phantom arm of <3mm,
indicating an accuracy of intervention sufficient for a 1cm diameter spherical lesion
while allowing for additional errors due to soft tissue registration and deformation in
further studies.
5.2.4 System Accuracy: Ex-Vivo Porcine Assessment
Phantom characterization is useful due to the fact that the target position is known
at all times, however it ignores some of the problems associated with intervention in
actual tissue. Most notably, the needle tip will move as a result of the motion imparted
by surrounding tissue. Additionally, tissue will deform due to the forces imposed by
an implantation needle. An ex-vivo porcine model was employed to further analyze
the system accuracy in the presence of the aforementioned difficulties.
The RCIGS system was used to guide intervention on simulated targets in porcine
lungs (BioQuest, eNasco). The lungs were preserved in proplyene glycol, which pre-
vents bacteria growth as well as acts as a dessicant to prevent the lungs from drying
out and becoming rigid. The lungs were placed inside of a plastic container supported
with foam (Figure 5.10). The trachea was held rigidly, the lateral and posterior sides
were supported, with the superior and anterior sides of the lung free to move. The
lungs could slide with respect to the container. These efforts were made in order to
maximize the amount of superior/inferior and anterior/posterior motion similar to
that found in-vivo. Twelve highly attenuating small pieces of 23 gauge copper wire
were percutaneously implanted through a Teflon guide sheath into three sets of lungs
to serve as targets.
The lungs were attached to a ventilator (Aequitron Medical, LP10) and inflated via
positive pressure. The ventilation parameters were 30 bpm, 1.8 liter volume, with 1.2
seconds inspiration time. The pressure exterior of the lung inside the housing was
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Figure 5.9: Lung IGS Phantom Study Schematic. A 4D motion phantom recreates
realistic motion trajectories. A bellows device receives the respiratory signal via a
surrogate axis and a computer calculates the target position using a pre-calibrated
5D model. This information is used to guide the physician on when to intervene.
When an intervention is performed, the position of an AxiEM marker on the motion
phantom arm is recorded along with the position of the surgeon’s tool tip. This
allows for quantitative analysis of the accuracy of the temporal guidance system.
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Figure 5.10: Porcine Lungs. The lungs were affixed in a housing which maximized
the amount of anterior/posterior and superior/inferior motion by restricting the
lateral edges. The lungs were attached to ventilator and inflated via positive
pressure.
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unregulated at atmospheric pressure. The expiratory pressure remained constant
from breath to breath at 20mm H2O via a positive end expiratory pressure (PEEP)
valve.
The RCIGS system was used to image, plan, and intervene on each of the targets
within the lungs. Point based registration was performed on circular CT contrast
markers affixed to the container holding the lungs.
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Figure 5.11: Surgical tools. An AxiEM stylette with PEEK guide sheath/needle as
well as a bare AxiEM stylette are shown.
During intervention, the EM tool (Figure 5.11) was affixed inside of a piece of 16
gauge Teflon tubing (Small Parts inc.) in which the leading end was cut at an acute
angle. The wall thickness of the tubing was high (0.4mm) in order to provide rigidity
and effectively make the Teflon guide sheath a needle capable of piercing lung tissue.
The EM tool and guide sheath combination was advanced during expiration when the
target was in the static approach path defined during planning. Once in place, the
EM tool was removed and a piece of copper wire was inserted into the guide sheath.
The entire assembly was fixed in place with cyanoacrylate and after all interventions
were performed the lungs were imaged again via 4DCT for interventional accuracy
assessment. After imaging, the exhalation 4DCT was loaded into clinical radiation
therapy treatment planning software (Philips Pinnacle version 8.1y) in order to define
the needle tip and target points in 3D (Figure 5.12). Error analysis was performed
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in order to define the three dimensional distance between the needle tips and target
points.
Figure 5.12: Target/Intervention accuracy assessment. The needle tip and target
are defined inside of clinical treatment planning software. The 3D offset is recorded
for each run. Yellow grid marks = 1cm increments.
5.2.5 System Accuracy: Human Cadaver Assessment
Additional concerns arise when using the RCIGS system for intervention in the human
lung. For instance, the approach plan must account for both rib and critical structure
motion such as vasculature to ensure the needle doesn’t interfere. Additionally, the
registration technique used for the porcine trial is not applicable in a human cadaver.
In order to determine the system accuracy in a clinically relevant scenerio, a human
cadaver was utilized.
The thorax of a human cadaver was prepared for respiratory correlated intervention.
The carbon fiber couch on a Philips Brilliance CT Scanner was replaced with a wood
plan in order to minimize interference with the magnetic fields required for 3D tool
location. The torso was placed on the couch and bilateral chest tubes were implanted
and affixed to a vacuum unit with a reservoir chamber to collect effusion fluid (Pleur-
Evac). Once the pleural space was evacuated, a cuffed endotracheal tube was inserted
and connected to a ventilator to inflate the lungs via positive pressure. The settings on
the ventilator were as follows: volume = 1 liter, breath per minute = 14, inspiratory
time = 1 second, assist/control mode. The torso was imaged via CT to determine
optimal locations for target implantation. Four small radiopaque markers constructed
of single stranded copper wire were implanted percutaneously into the lungs to serve
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as targets. The targets were implanted laterally through a needle with a plunger to
evacuate the targets. The targets were implanted with distances of approximately
10cm from the anterior surface to ensure the system is accurate for intervention on
deep lesions.
Once the targets were implanted, several circular radiopaque CT markers were affixed
to the chest wall and the cadaver was imaged via 4DCT (Figure 5.13). Similarly to
the previous porcine and phantom models, point based registration was performed
using the CT markers. Unlike the previous models, the registration points are moving
due to respiratory induced chest wall expansion and hence the registration must be
gated at exhalation. Additionally, a patient tracker EM sensor is affixed to the torso.
This sensor also moves/rotates due to chest wall motion. The position of the EM tool
is constantly updated based on a coordinate system transformation obtained from
the patient tracker. As a result, the position of any EM tracked tool is only accurate
during the phase at which registration was performed (exhalation). This is acceptable
due to the fact that intervention and needle advancement will be gated at the same
phase that registration was performed.
Figure 5.13: Cadaver Registration. Several small radiopaque CT contrast markers
were affixed to the chest wall for registration. The markers have a circular hole in
the middle, which is the same size as the head of an EM tool. The tool is touched in
each of the markers during exhalation, and the StealthStation matches these points
in CT room coordinates (with respect to the black magnetic field generator) with
the associated points defined on the CT image.
A guide sheath constructed of polyetheretherketone (PEEK) was placed around the
EM tool to be used for intervention. PEEK was employed as opposed to the PTFE
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(Teflon) tubing used in the porcine model due to the need for a stronger polymer in
order to penetrate the chest wall and tissue surrounding the lungs. A metal guide
sheath would act as a Faraday cage, shielding the inner tool from the magnetic field
and preventing 3D localization. PEEK offers rigidity comparable to steel in a non-
ferromagnetic material. The tool/sheath was advanced through a small incision on
the anterior surface of the torso. This approach path is different than the lateral
path used to implant the targets to ensure the intervention needle was not simply
following the hole in the tissue made during target implantation. Once the EM tool
was guided to the appropriate position, it was removed from the guide sheath and a
piece of copper wire was inserted and affixed with cyanoacrylate. The copper wire is
readily visible via CT imaging and was used to determine the efficacy of intervention.
5.3 Results
5.3.1 Phantom Assessment
Since the trajectory delivered from the phantom is known, this makes it possible to
characterize the accuracy of each step of the RCIGS process. The first stage of the
process is model calibration via the target locations on a segmented 4DCT image.
The calibrated 5D model positions were compared with the actual positions delivered
by the motion phantom during imaging to determine the 3D error at the end of this
stage. A histogram of the errors is shown in Figure 5.14. Additionally, a histogram
of the errors within the exhalation gating window is shown. Note that the errors
from modeling decrease when observing exhalation vs. the entire breathing waveform
(mean: 0.8 vs. 0.9mm; max: 2.0 vs. 2.9mm respectively).
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Figure 5.14: Lung Motion: Modeling Errors. The output from the 5D model used to
determine the tumor position during treatment was compared with the actual
tumor trajectory. Errors are reported for the entire waveform (blue) as well as only
at exhalation (yellow).
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Once the model was shown to be accurate, intervention was performed as described in
the methods section. A total of 25 interventions on a moving target were performed.
Errors from the interventions are reported in Figure 5.15. The intervention showed
good agreement with a mean error of 2.0mm and a maximum error of 3.3mm.
Figure 5.15: Lung Motion: Phantom Intervention Errors. Intervention was
performed on a moving target. A histogram of the errors from 25 interventions in
shown.
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Table 5.1: Porcine Intervention Accuracies. The target to needle tip errors are
reported. Additionally, the target motion and depth are reported.
5.3.2 Porcine Assessment
In Figure 5.12, CT images of the target and tooltip are displayed. Additionally,
table 5.1 contains the 3D error between the target and tooltip for each run. 9/12
intervention attempts provided accuracy suitable for intervention on a 1cm tumor.
All attempts provided accuracies capable of intervening on a 1.5 cm diameter tumor.
The mean error associated with intervention was 3.8mm (SD=0.8mm).
5.3.3 Cadaver Assessment
The RCIGS system displayed excellent accuracy in the human cadaver interventions.
The table of geometric errors, equivalent tumor biopsy diameter, target depth and
target motion is displayed in Table 5.2. The mean accuracy of intervention was
found to be 4.0mm, with a mean target depth of 9cm. All target/tooltip errors were
less than 5mm, which indicates intervention is suitable for 1cm tumors in 4/4 cases.
Additionally, the target depths were large (7-10 cm). As a result, if a target was
implanted at a depth larger than this, it is likely the intervention would have been
performed from the posterior chest wall as opposed to anterior.
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Table 5.2: Cadaver Intervention Accuracies. The target to needle tip errors are
reported. Additionally, the target motion and depth are reported.
The motion for the first two targets was minimal (2mm). These targets were both
implanted in the right lung of the patient, which had substantial fluid to be drained
prior to implantation/intervention (Figure 5.16). The fluid in the pleural space col-
lapsed the lung substantially prior to draining via chest tubes, and as a result the
lung possibly exhibited less motion.
Figure 5.16: Pleural Effusion. Substantial fluid buildup (A) was present in one lung
prior to draining via a chest tube affixed to a vacuum source. The lung was
collapsed (B) prior to draining and this might have reduced the amount of
respiratory related target motion for the two targets implanted into this lung. The
right is a CT of the same lung after draining the fluid.
5.4 Discussion
The RCIGS system shows promise for minimally invasive intervention in the lung/abdomen.
There are several commercial systems on the market to currently address the prob-
lem, but to date none have published results encompassing the accuracy of the system
from start to finish for interventions in the lung.
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One group from Georgetown University has showcased their IGS software based on
the open source Image Guided Surgery Toolkit (IGSTK).[3] In this study, three live
swine were implanted with tumor analogues. The swine were sedated and intervention
was performed to determine the accuracy of the guidance system in the presence of
respiratory motion. The errors reported were substantially higher than our system
(9.4±3.0mm vs 4.0±0.8mm).
There are improvements to the RCIGS package that would need to be made prior to
a clinical implementation. In practice, it is unlikely a pulmonologist would refer a
patient to an imaging center at a remote location in order to obtain the 4DCT for
respiratory correlated intervention planning. Aside from workflow efficiency concerns,
having the patient move between imaging and intervention has the potential to in-
crease registration error. A mobile, compact system for performing CT acquisition has
been developed (O-arm Surgical Imaging, Medtronic Navigation). A CT system capa-
ble of imaging within a pulmonary intervention suite would allow for increased patient
throughput. Additionally, the acquired images would be automatically registered to
room coordinates, which alleviates the need for point based registration. This would
allow for workflow improvements as well as decrease the errors associated with do-
ing registration on moving soft tissue body surfaces. Bronchoscopic intervention[26]
is typically favored over percutaneous intervention[105] due to the reduced rate of
pneumothorax. Development of flexible tools would allow for intervention through




In 2006, respiratory correlated imaging was recently seeing clinical acceptance for
modeling lung tumor motion and guiding treatment decisions. Volumetric imaging
was used for daily alignment, however there was no respiratory correlated imaging
used at time of treatment. An external marker block system (RPM, Varian Medi-
cal Systems) for gating the treatment beam based on respiration was starting to see
adoption in clinical practice, however internal fiducial based systems, such as that
offered by Calypso Medical, were not FDA cleared for use in any anatomical location.
Since 2006 there have been many significant milestones in clinical radiation therapy
technology development. After obtaining FDA clearance for use in the prostate, the
Calypso system has been routinely used for daily clinical alignment. Additionally, our
group worked in conjunction with Calypso Medical to develop a modified transpon-
der with stabilizing legs that allow for fixation when deployed in the lung. This
transponder has recently been implanted in 9/2010 into the first human lung cancer
patient. Gating via internal electromagnetic transponders has been through FDA
510k approval and will be implemented clinically in the near future. DMLC guidance
has been thoroughly quantified and tested, and once proper safety checks and quality
assurance measures are in place, it will see clinical implementation in the next two
years.
The use of electromagnetic position monitoring in radiation oncology has been ex-
plored, however there are many potential improvements. Implanted transponder po-
sition knowledge throughout treatment can be used for more than just guiding the
radiation dose in real-time. As shown in the previous chapters, even an accurate guid-
ance system using the effectors we have developed still has geometric and dosimetric
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errors over the course of treatment. A system that could model the dose actually de-
livered to internal structures would allow for adaptive planning. One could propose a
system in which the gating/DMLC tracking systems were implemented. After daily
treatment, the positions of the transponders and correlated beam-on information are
loaded into a deformable modeling application to determine the location of internal
structures based on the locations of internal transponders throughout the treatment.
The dose is then calculated on a voxel-by-voxel basis using the deformed organ posi-
tion maps and correlated treatment beam information. The dose for subsequent treat-
ments could then be modified to account for hot/cold spots from motion/alignment
errors in previous fractions. If this adaptive system was sufficiently accurate, it has
the potential to provide a drastic reduction in treatment margins; which would allow
for dose escalation due to reduction in irradiated healthy tissue.
Internal markers have been shown to be safe for implantation and have displayed
promise for guiding external beam radiation therapy, however there are room for
improvements. They provide high temporal resolution but low spatial resolution (only
1-3 markers conventionally). This is complementary to the high spatial resolution but
low temporal resolution offered by current volumetric imaging modalities. Markers
have the potential to be implanted into more anatomical locations. Lung implantation
has been explored, but is not currently FDA approved. Additional locations include
the abdomen or breast tissue. For breast radiation therapy, an alternative solution
to the Calypso transponder might be of interest. The transponder is effectively a
wire coil, which are not for use in an MRI environment. Since external beam breast
therapy is conventionally coupled with a follow up MRI, this means the transponder
would have to be removed prior to imaging. An alternative solution from Navotek uses
minute radioactive sources implanted in the body. The source can be localized with
respect to the linear accelerator head, and the 3D position calculated. The dose from
the sources is negligible when compared to that of a conventional radiation therapy
treatment, and the source can remain in place following the treatment. Additionally,
the sources can be made considerably smaller than the Calypso Beacon transponders,
however the system is limited to a single source due to the fact that multiple sources
would give a continuous signal which correlates to the superposition of the sources.
This means the applications are limited to solely spatial position knowledge, where
rotation is not of interest.
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A combined cobalt gamma ray source and MRI machine is currently under devel-
opment (Renaissance System, Viewray Inc.). Non-ionizing imaging available during
treatment would provide target volumes and locations in real-time. Techniques re-
liant on real-time imaging to determine the position of internal anatomy throughout
the treatment session could provide more information than a small number of internal
fiducial positions. Currently, the computational power is not available for decision
making based on real-time image segmentation. However, there are efforts being
focused on this technology and it is likely to be implemented in the near future. Vol-
umetric imaging throughout the treatment could potentially allow for the adaptive
therapy described previously without the need for deformation modeling based on
internal fiducials.
The RCIGS package has further development prior to being ready for a clinical im-
plementation. As mentioned in the discussion, integration with an in-room movable
CT scanner (Medtronic O-arm) would be ideal. There is work to be done in order
to use the current O-arm for respiratory correlated surgical applications. First, the
reconstructed field of view needs to be expanded in order to allow for large plan-
ning volumes such as the thorax. Additionally, respiratory correlated imaging is not
currently available. A prospective 4DCT acquisition protocol could be developed in
which images were only acquired when the patient is at the tidal volume of interest.
This method would not only limit the imaging dose to the patient, but provide for less
computationally expensive reconstruction times when compared with those of retro-
spective 4DCT. Additional porcine and cadaver trials will be necessary to ensure the
system is robust, but will likely come after integration with the additional hardware.
Radiation therapy tumor tracking has seen substantial improvements in the past sev-
eral years. Additional advancements in tracking technologies and adaptive radiation
therapy planning will further our work. Image guided surgery is still a relatively new
field. Surgeons conventionally have less time than radiation oncologists to learn new
technologies related to respiratory motion management. Taking the radiation ther-
apy concepts routinely used in the clinic and applying them to further a respiratory
correlated image guided surgery package has the potential to improve diagnostic and




4DCT four dimensional (respiratory correlated) computed tomography
BEV beams eye view
CT computed tomography
CTV clinical target volume
DMLC dynamic multileaf collimator
DTA distance to agreement
EPID electronic portal imaging device
IGS image guided surgery
IMRT intensity modulated radiation therapy
LINAC linear accelerator
MLC multileaf collimator ...
NSCLC non small cell lung cancer
OBI on board imaging
PTV planning target volume
RF radio frequency
RTRT real-time radiotherapy





In external beam radiation therapy, the source of ionizing radiation must pass through
healthy tissue between the radiation source and the target site. Typically several dif-
ferent beam angles are used to irradiate the target and spread the dose to surround-
ing healthy tissue. In conventional linear accelerator (linac) setups, the entire gantry
rotates around the patient to spread the dose to surrounding structures while con-
tinuously irradiating the target. This rotating gantry provides multiple beam angles
to irradiate a single target site. Coupled with a couch that translates and rotates,
non-coplaner beams can be utilized for special cases when avoiding critical structures
surrounding the target (e.g. spinal cord, rectum).
Tumors are not uniform in size or shape, and as a result efforts are made to pro-
duce custom treatments on a per-patient basis. This has led to the use of multileaf
collimators (MLCs) attached to the heads of traditional linear accelerator gantries.
MLCs are composed of a series of heavy metal (typically tungsten) leaves that highly
attenuate the x-rays emitting from the linear accelerator. The leaves are arranged in
parallel and can be moved independently with one degree of freedom. The addition
of MLCs allows for conformal radiation therapy, in which an aperture is defined for
every beam angle that constricts the beam to the target’s shape from the particular
beam’s eye view (BEV). It has been shown that the addition of conformal therapy
allows for dose escalation, which has a positive effect on clinical outcomes [112].
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B.2 4DCT
Computed tomography (CT) has become a widely used method for volumetric imag-
ing in both clinical and basic science applications. Conventional CT provides high-
resolution tomographic images with high contrast. Although traditional CT images
are static in time, a technique known as 4DCT has been developed to image anatomy
as it moves due to the respiratory cycle [69, 11, 67]. The final output from a 4DCT
is a series of 3D volumetric images in which each 3D image contains the location of
the anatomy from a given phase/amplitude of the respiratory cycle.
At Washington University in St. Louis, a 4DCT imageset is acquired using the follow-
ing method [44]. The patient is placed on the CT couch, and a respiratory surrogate
such as a bellows and/or spirometer is affixed. This surrogate will simultaneously
record the respiratory waveform throughout image acquisition. A computer receives
this respiration signal along with the x-ray ON signal from the CT scanner, and as
a result each acquired 2D tomographic image slice can be correlated with respect to
the respiration waveform. Each 2D axial slice is oversampled in order to ensure that
the given slice is acquired at each phase of the breathing cycle. For instance, if the
intended 4DCT will be reconstructed at 10 phases, the output will be 10 volumetric
3D CT images each with all the anatomy corresponding to a given phase/amplitude.
For this hypothetical acquisition, 25 images for each slice might be acquired to en-
sure that the phase of at least one of the images for that slice matches each of the 10
reconstructed phases.
At completion, 4DCT provides CT resolution images with temporal changes in in-
ternal anatomy. One of the concerns associated with this technique is increased
radiation dose to the patient due to the oversampling required to generate the 4DCT.
For patients undergoing radiation therapy, this concern is minimal compared to the
dose associated with the treatment. For alternative applications, the benefits of the




MLCs have been widely adopted in clinical use for conformal radiation therapy. In
an effort to increase dose conformality to the target, many treatment centers have
implemented Intensity Modulated Radiation Therapy (IMRT). It has been shown that
IMRT delivery improves dose conformality over conformal radiation therapy [111]. In
IMRT planning, critical structures are defined via manual contouring, and constraints
are set to ensure proper dose to the target and dose limits to surrounding healthy
structures. After a dosimetrist defines all the constraints, an iterative algorithm
calculates the best intensity profile to deliver from each beam angle in order to satisfy
the initial conditions. There are two major types of IMRT delivery, S-IMRT and D-
IMRT.
B.3.1 S-IMRT
In S-IMRT delivery, during the planning stage a dosimetrist divides each beam angle
into a series of segments. These segments are composed of different leaf sequences for
a given beam angle, delivering a series of small static conformal beams for each angle.
During delivery for a given beam angle, the leaves are aligned to the first segment and
the beam is turned on. The dose prescribed for a given segment is delivered and at
completion the beam is turned off. The leaves then move to their respective positions
for the next segment and the beam is turned on again. In S-IMRT the leaves are
never moving when the beam is on, and as a result this technique is often referred
to as ‘Step and Shoot’ IMRT. During the planning phase, the segments are adjusted
to ensure coverage of the target while minimizing hotspots in the dose profile. At
completion, the plan contains a series of beam angles, and a series of segments for
each angle.
B.3.2 D-IMRT
In D-IMRT the plans are developed computationally. For each beam angle the fluence
for each pixel in the beam’s eye view (BEV) is defined independently. Throughout
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delivery the beam is enabled while the leaves are moving. The leaf pairs move such
that for a given pixel in the BEV plane, the time between the leading leaf exposing
a given pixel and the following leaf shielding a given pixel is sufficient to deliver the








m= moment in time (conventionally measured in monitor units)
x = position along the direction of leaf motion
I(x)= intensity
vr= velocity of the right (leading) leaf
vl= velocity of the left (trailing) leaf
B.4 Dosimetric Analysis
In order to determine the effectiveness of various motion management techniques,
dosimetric analysis is performed to quantitatively analyze the level at which the
dose in the presence of motion (target image) matches the dose in the absence of
motion (reference image). Dose is conventionally measured by dosimetric film, or
arrays of ion chambers or diodes. There are a number of metrics for quantitatively
comparing dosimetric accuracy. A brief overview of the most common dosimetric
analysis techniques is included below.
B.4.1 Difference Maps
In difference maps, the dose from the reference image is subtracted from that of the
target image on a pixel-by-pixel basis. As a result, positive values indicate overdosing
and negative values indicate under dosing. In areas of very steep dose gradients, a
very small spatial offset can lead to drastic dosimetric differences.
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B.4.2 Distance to Agreement (DTA)
In the distance to agreement, the dose value for each pixel in the target image is
compared to values in the surrounding area on the reference image. The minimum
distance needed to find a corresponding dose value is recorded, using interpolation
for discretized dose distributions. The DTA function is complementary to difference
mapping in that it returns large values for relatively small dose differences in regions
of shallow dose gradient.
B.4.3 Gamma (γ) Tool
The γ tool effectively combines both dose difference and distance to agreement metrics
which each break down in steep and shallow dose gradient regions respectively. The










(~re, ~rr)= the positions on the evaluated
and reference images respectively
r(~re, ~rr) = the spatial distance between the two points (~re, ~rr)
δ(~re, ~rr)= the difference between the
evaluated dose and the reference dose
∆d= the distance to agreement criterion (typically 3mm)
∆D= the dose agreement criterion (typically 3% of the max dose)
We leave out the details for the sake of brevity; however further information on the
γ tool can be found in the literature [45].
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B.5 Intra/Inter -fraction motion
Due to the complicated nature and computational load associated with planning
treatments, it is not currently clinically feasible to replan the patient at each fraction
using daily volumetric imaging. With this in mind, at each fraction the patient is
typically aligned via bony anatomy on orthogonal fluoroscopy images obtained at
time of treatment. It is possible that although the bony anatomy is in the same
location, the internal soft tissue may not be in the same location. Inter-fraction
motion, or motion associated with repositioning the patient on the table between
fractions, causes significant error in terms of target localization. In addition, intra-
fraction motion can come in many forms. Many target sites are associated with intra-
fraction motion (e.g. respiratory correlated motion in the lung and prostate shifts
due to rectal filling). With this in mind, margins are added to the Clinical Target
Volume (CTV) in order to ensure proper coverage when accounting for uncertainty
in target position. The resulting Planning Target Volume (PTV) is then used for
treatment planning [57]. Reducing the uncertainty in target location can lead to a
reduction in PTV margins and allow for dose escalation to the target site.
Figure B.1: The Washington University 4D Phantom.
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B.6 Washington University 4D Phantom
In order to evaluate the accuracy of methods for mitigating respiratory motion, it
is necessary to recreate patient motion with precision and accuracy. With this in
mind, a 4D phantom was developed capable of reproducing motion to sub millimeter
accuracy [52]. The phantom, shown in Figure B.1, contains a platform capable of
holding a load sufficient for carrying dosimetric phantoms. It is composed of a four
axis motion controller that can be loaded with a custom trajectory at 100hz. Once
programmed with a trajectory, the phantom can recreate motion in three dimensions
using orthogonally placed stepper motors as well as offer a fourth surrogate axis for
independant motion analogous to a respiratory surrogate signal. For many charac-
terization studies described herein, the 4D phantom was used to accurately recreate
patient breathing trajectories.
Figure B.2: Lung motion model. The motion of the object at baseline (circle) is
shown at a given phase point (square). Component vectors related to the tidal
volume (~rv) and airflow (~rf ) predict the position of the object (~rp) with respect to
baseline ( ~rp0) at any phase of the breathing cycle.
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B.7 Respiratory Motion Model
The ability to accurately predict tissue motion within the lung as it moves due to res-
piration is useful for a variety of interventional applications. A respiratory correlated
lung motion model has been developed which relies on the signal from an external
respiratory surrogate (spirometry) to correlate internal tissue motion with tidal vol-
ume and airflow in the lung. [45]. As described visually in Figure B.2 the position of
an object within the lung can be predicted based on two independent vectors (rˆv, rˆf )
related to the tidal volume and airflow respectively. Typically the main portion of
motion is derived from tidal volume changes in the lung. Hysteresis occurs due to air-
flow derived local pressure differences, and this motion is accounted for by the second
vector rˆf . Conventionally the model is calibrated using the position of the target on
a 4DCT image set obtained either via manual segmentation or automatic template
matching for high contrast easily identifiable landmarks. Once the 3D target position
along with the mean tidal volume and flow is delineated for each phase of the 4DCT,
these parameters can be used to calibrate the 5D model. The model yields the target
position based on the external surrogate for any tidal volume/airflow as described in
equation B.3. Research is ongoing confirming the accuracy of this model for clinical
applications.
~rp = αvrˆv + βfrˆf (B.3)
where
~rp0= the baseline position at exhalation.
~rp= the vector offset from baseline position ~rp0
α, β = Model constants (tidal volume, airflow respectively)




B.8 Target Localization Techniques
Respiratory correlation has been used extensively in CT and MR imaging in an effort
to reduce breathing related image artifacts [75, 69]. More recently, similar techniques
have been employed to localize the tumor and gate (turn on/off) the linear acceler-
ator [91, 49, 35]. Conventional gating setups use a variety of techniques to measure
breathing motion including: optically tracked external marker blocks, thermocouples,
thermistors, strain gauges, and pneumotachographs [38]. Current techniques rely on
the use of external markers or sensors to determine the internal position of the target.
If a relationship between the external surrogate and the internal target position can
be established, the beam can be turned off or ‘gated’ when the target is outside of the
delivery volume. Although a correlation exists between external markers and internal
tumor position, for some patients’ external marker trajectories do not serve as an
adequate surrogate for internal tumor position [16].
Respiration induces considerable deformation within the thoracic cavity. As the di-
aphragm contracts, internal anatomy compresses and distends. Often the external
anatomy exhibits good correlation with the motion of the internal structures such
as the diaphragm and/or lung tumors [49, 16]. The external anatomy moves due
to respiration; however studies have shown considerable differences between external
anatomy and internal motion. These differences can come in the form of correlated
motion with a phase lag between the external and internal motion, or less frequently
the motion might not exhibit correlation. Margeras and Yorke have reported up to a
0.5 second lag between Varian RPM marker block position and diaphragm position
measured fluoroscopically [50]. Koch et al found that correlation was poor and unsta-
ble unless the external surrogate measuring skin surface position was near the tumor
[36]. In a study from Berbeco et al, lung tumor motion was measured via continuous
fluoroscopy concurrently with measurement of external abdominal surface positions
[7]. The amount of residual tumor motion, defined as the amount of tumor motion
during a respiratory gate based upon the movement of the external surrogate, showed
large fluctuations (>300%) for both intra- and inter-fraction motion. The residual
motion was found to be up to 8 mm in magnitude, which strongly suggests that exter-
nal position monitoring cannot accurately reflect the internal position of a tumor for
all cases. The periods in which external and internal motion exhibit poor correlation
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are often transient; however these transient periods have dosimetric implications [68].
The lack of correlation between internal/external positions has led investigators to
examine alternative techniques for accurately tracking the position of targets inside
the thoracic cavity. Shirato et al developed a real-time target tracking system that
uses four integrated kilovoltage imaging systems [89]. The fluoroscopic imaging sys-
tem used in this technique provides accurate information on the location of discrete
points inside the abdomen. However, accurate tracking of the target comes at the
expense of an increased imaging dose. For a single fluoroscope, the estimated skin
surface dose rate can be up to 118 cGy/h [93]. In addition, for 3D target tracking,
stereoscopic fluoroscopes are necessary which means further accumulated dose due to
imaging. The SynchronyTMRespiratory Tracking System (RTS) treatment option of
the CyberKnife robotic radiotherapy system provides another image based system for
tracking internal fiducial markers [85]. With this technique, gold fiducials are placed
inside the thoracic cavity near the tumor while the patient wears a vest with LEDs
that indicate the position of the chest and abdomen. Before the treatment begins, a
series of orthogonal x-ray images are acquired that are used to correlate the position
of the external markers to the internal fiducials. A correspondence model is developed
and periodic images are obtained during the course of delivery to ensure the continued
validity of the correspondence model. While the SynchronyTMRTS delivers a lower
radiation dose to the patient as compared to continuous fluoroscopic imaging, this
is achieved at the expense of intermittent absolute knowledge of internal positions.
Previous studies state that the entrance dose per image can be as high as 0.2 cGy [64].
For a 2-hour session with imaging performed every 30 seconds, the patient receives
48 cGy over the course of the treatment due to imaging.
Alternative image based solutions have been investigated which utilize the on board
imaging (OBI) functionality of many modern linear accelerators [6]. Similarly to the
fluoroscopy based solutions previously mentioned, OBI solutions deliver dose to the
patient in order to image and track internal markers/tumors. Another factor limit-
ing this technique is the fact that high energy MV scatter from the treatment beam
can degrade the image quality of the kV images typically used for tracking [48]. OBI
based methods do have the advantage of providing information about the surrounding
tissue, which a pure electromagnetic position monitoring solution cannot provide.
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B.9 Calypso Electromagnetic Position Monitoring
Continuous electromagnetic position monitoring is now available without additional
dose to the patient (Calypso Medical, Seattle WA). The system uses one or more
wireless transponders which are subject to performance testing as part of the manu-
facturing operation to ensure they can stand up to high levels of radiation throughout
the treatment process. The transponders are implanted into the patient via a 14-gauge
needle in a procedure similar to existing gold fiducial implants currently in use clin-
ically. During treatment planning, the location of the transponders is recorded with
respect to isocenter, and a plan is developed.
During delivery, an array is placed above the patient. Four source coils in the array
excite the transponders via magnetic induction. After excitation, 32 receiver coils
in the array detect the resulting response signal. Each transponder contains and
RLC circuit tuned to a unique resonant frequency (300kHz, 400kHz, or 500kHz), and
they are sequentially excited in order to independently query position information.
When the array excites at a particular frequency, only the transponder tuned to that
frequency can store the energy to later emit back to the array for detection. For a




is registered to the room via stereoscopic infrared cameras, and hence the transponder
position is known with respect to the room isocenter.
Balter et al have reported submillimeter accuracy when tracking the transponders
moving at 3 cm/s in a volume that is 14x14 cm in width, and up to 27 cm away from
the array [2]. In a study from Santanam et al the system was again found to be sub-
mm accurate as confirmed by onboard kilovoltage imaging [78]. In a clinical prostate
cancer treatment study, Willoughby et al have shown the system to be functional in
a linac environment, even when the linac is treating directly through the array [108].
To date there have been no published failures of the transponders due to radiation
dose. The system is currently FDA cleared for use in the prostate, and potential
applications in the lung and abdomen (where motion is substantial) are promising.
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B.10 Medtronic StealthStation
The Medtronic StealthStation (pictured Figure 5.1) is an IGS system for minimally
invasive surgical procedures. The StealthStation AxiEM technology provides elec-
tromagnetic tracking of wired instruments within the body. In this EM tracking
implementation, a position varient magnetic field is generated within the patient us-
ing three orthogonal coils contained inside of the field generator. Tools for the AxiEM
system have one or more coils near the tip, and upon entering the magnetic field a
position dependent current is induced. The tools are connected via a wire back to
the StealthStation and the amplitude of the induced current allows for continuous 3D
localization.
AxiEM tools offer some advantages over optically tracked IGS systems. First, line of
sight is not required to track the tools. Additionally, using single-coil tools allows for
the potential of flexible tools that could be implanted via a bronchoscope. Optical
tools require the tool to be rigid with respect to the optical base which is tracked
outside of the body. If the tip of the optical tool bends during implantation with
respect to the base, the localization error of the tip will be large.
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